(S)-Methyl 1-Methyl-4,9-Dihydro-3H-Pyrido[3,4-B]Indole-3-Carboxylate Hydroiodide, 98%, 100mg

Methyl 6-(dimethylphosphoryl)nicotinate, 98%, 100mg

2-Oxa-6-azaspiro[3.4]octan-7-one, 95.0%, 5g

4-(Difluoromethylsulfonyl)benzoic acid, 95%, 250mg

(1-(Methoxycarbonyl)-1H-indol-2-yl)boronic acid, 95%, 10g

N-(3-(5-Bromo-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide, 98%, 250mg

2-Bromo-4'-phenylacetophenone>98.0%(GC)(T)25g

ETHYL 2-AMINO-5-BOC-6,7-DIHYDRO-4H-THIENO[3,2-C]PYRIDINE-3-CARBOXYLATE, 95.0%, 1g

tert-butyl 7-hydroxy-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate, 95.0%, 500mg

Analytical and precision scale Entris® II series Models with internal adjustment, not certified, 0.01 g, 3200 g, BCE3202i-1S

1-methyl-3-(pyridin-3-yl)-1H-pyrazole-5-carboxylic acid, 95.0%, 500mg

N-tert-Butylurea, 10g

N,N-bis(2-methoxyethyl)methanesulfonamide, 95.0%, 250mg